EPO and anemia: Anemia is a common problem among patients with chronic kidney disease (CKD).1 Several mechanisms are involved including iron deficiency and decreased production of erythropoietin stimulating agents (ESAs).2-3 As CKD progresses to end-stage renal disease (ESRD), anemia tends to worsen, and management becomes more complicated.